Timothy P. Clackson's Insider Trades & SAST Disclosures
Timothy P. Clackson's most recent trade in Elevation Oncology Inc was a trade of 35,000 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on June 13, 2024.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Timothy P. Clackson.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Elevation Oncology Inc | Timothy P. Clackson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Jun 2024 | 35,000 | 35,000 | - | - | Stock Option (Right to Buy) | |
| Elevation Oncology Inc | Timothy P. Clackson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Jun 2023 | 31,238 | 31,238 | - | - | Stock Option (Right to Buy) | |
| Theseus Pharmaceuticals Inc | Timothy P. Clackson | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2023 | 45,625 | 45,625 | - | - | Restricted Stock Units | |
| Theseus Pharmaceuticals Inc | Timothy P. Clackson | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Feb 2023 | 273,750 | 273,750 | - | - | Stock Option (right to buy) | |
| Theseus Pharmaceuticals Inc | Timothy P. Clackson | Director, President and CEO | Purchase of securities on an exchange or from another person at price $ 6.80 per share. | 11 Nov 2022 | 2,500 | 351,030 | - | 6.8 | 16,995 | Common Stock |
| Elevation Oncology Inc | Timothy P. Clackson | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 17 Jun 2022 | 31,553 | 15,777 | - | 0 | Common Stock | |
| Elevation Oncology Inc | Timothy P. Clackson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jun 2022 | 15,619 | 15,619 | - | - | Stock Option (Right to Buy) | |
| Theseus Pharmaceuticals Inc | Timothy P. Clackson | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Feb 2022 | 450,000 | 450,000 | - | - | Stock Option (right to buy) | |
| Theseus Pharmaceuticals Inc | Timothy P. Clackson | Director, President and CEO | Purchase of securities on an exchange or from another person at price $ 9.76 per share. | 21 Dec 2021 | 2,600 | 348,530 | - | 9.8 | 25,381 | Common Stock |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges